A clinical trail on 30 female patients to check the efficacy of Shatavari Churna in reducing the symptoms of Premenstrual Syndrome

A single-arm clinical trail to evaluate the efficacy of Shatavari Churna in Premenstrual Syndrome

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053305

Enrollment

Registered

2023-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F59- Unspecified behavioral syndromes associated with physiological disturbances and physical factors

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients within the age group 16-40 years, who will give their written consent and who will agree to follow the protocol of study. Patient fulfilling the diagnostic criteria according to PMS Scale screening, not using any hormonal contraceptives, having a regular menstrual cycle and medication free

Exclusion criteria

Exclusion criteria: Diagnosed case of psychiatric disorder, pelvic pathology or Premenstrual dysphoric disorder

Design outcomes

Primary

Measure	Time frame
The effect of treatment will be accessed based on detailed case proforma, adopting scoring methods based on questionnaire on PMS Scale, published in International Journal of Advances in Nursing Management. Pre and post interventional assessment will be done and gradedTimepoint: At baseline 14 days prior to cycle 1 of menstruation, 1st day of cycle 1, 1st day of cycle 2, 1st day of cycle 3 of consecutive menstruation	—

Measure

Time frame

The effect of treatment will be accessed based on detailed case proforma, adopting scoring methods based on questionnaire on PMS Scale, published in International Journal of Advances in Nursing Management. Pre and post interventional assessment will be done and gradedTimepoint: At baseline 14 days prior to cycle 1 of menstruation, 1st day of cycle 1, 1st day of cycle 2, 1st day of cycle 3 of consecutive menstruation

—

Secondary

Measure	Time frame
The effect of treatment will be accessed based on detailed case pro forma adopting scoring methods based on questionnaire based on PMS Scale published in International Journal of Advances in Nursing Management. Pre and post interventional assessment will be done and graded.Timepoint: Post menstrual bleeding of cycle1, cycle 2, cycle 3 consecutively	—

Countries

India

Contacts

Public ContactDR ARCHI MAMGAIN

Professor, Department of Prasuti Tantra and Stree Roga, Alvas Ayurveda Medical College and Hospital

drsumaranirajesh@gmail.com

Outcome results